Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis

OBJECTIVE

 To compare the use of mirabegron with anticholinergics drugs for the treatment of overactive bladder (OB).

DATA SOURCE

 Systematic searches were conducted in EMBASE, PUBMED, Cochrane, and LILACS databases from inception to September 2021. We included RCTs, women with clinically proven OB symptoms, studies that compared mirabegron to antimuscarinic drugs, and that evaluated the efficacy, safety or adherence.

DATA COLLECTION

 RevMan 5.4 was used to combine results across studies. We derived risk ratios (RRs) and mean differences with 95% CIs using a random-effects meta-analytic model. Cochrane Collaboration Tool and GRADE was applied for risk of bias and quality of the evidence.

DATA SYNTHESIS

 We included 14 studies with a total of 10,774 patients. Fewer total adverse events was reported in mirabegron group than in antimuscarinics group [RR 0.93 (0.89-0.98)]. The risk of gastrointestinal tract disorders and dry mouth were lower with mirabegron [RR 0,58 (0.48-0.68); 9375 patients; RR 0.44 (0.35-0.56), 9375 patients, respectively]. No difference was reported between mirabegron and antimuscarinics drugs for efficacy. The adherence to treatment was 87.7% in both groups [RR 0.99 (0.98-1.00)].

CONCLUSION

 Mirabegron and antimuscarinics have comparable efficacy and adherence rates; however, mirabegron showed fewer total and isolated adverse events.

Development of personalized molds for neovagina creation by 3D printer

OBJECTIVE

Additive Manufacturing (AM), also known as Rapid Prototyping, is a set of production technologies used in the synthesis of a particular physical object by adding layers to form a part based on data generated by Computer-Aided Design (CAD) systems. These technologies are widely used to quickly create prototypes of products and tools for commercial purposes. Over time, it has also been integrated with other areas, such as healthcare, since these tools have allowed health professionals to assist in diagnoses, surgical planning, and synthesis of orthoses and prostheses for patient rehabilitation. To develop models for the construction of dilators for the treatment of vaginal agenesis.

METHODS

Use CAD software and create a physical model using AM to analyze the viability of its production in the elaboration of customized dilators for each patient.

RESULTS

The production through AM provides an advantage in the development, facilitating physical alterations just by adjusting the three-dimensional models made by the software in a quick way, thus making the customization process viable.

CONCLUSION

The proposed procedure for the manufacture of dilators presented good results and technological feasibility, indicating that it can be a good solution for the production and customization of gynecological devices.